Capital Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,273
Closed -$211K 93
2025
Q1
$211K Sell
1,273
-255
-17% -$39.9K 0.06% 90
2024
Q4
$221K Buy
1,528
+183
+14% +$28.4K 0.06% 87
2024
Q3
$218K Buy
+1,345
New +$214K 0.06% 82

Other funds holding JNJ

Capital Planning's JNJ Position: Q2 2025 in Review

Capital Planning sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,273 shares — an estimated $211K sold.

Capital Planning first reported a position in JNJ in Q3 2024 and held it in 3 quarters. The position peaked at $221K in Q4 2024. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Capital Planning reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Capital Planning sold 1,273 Johnson & Johnson shares in Q2 2025, an estimated $211K.
  • Capital Planning first reported a position in Johnson & Johnson in Q3 2024 and held it in 3 quarters.
  • Capital Planning's Johnson & Johnson position peaked at $221K in Q4 2024.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Capital Planning's 13F filing for Q2 2025, filed 21 Jul 2025.